热门出版物 - 学术资源搜索

h5 指数:27
h5 中位数:49

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#15 AIDS & HIV

标题/作者	引用次数	年份
A review of the safety of favipiravir–a potential treatment in the COVID-19 pandemic? V Pilkington, T Pepperrell, A Hill Journal of Virus Eradication 6 (2), 45-51	186	2020
In vivo suppression of HIV rebound by didehydro-Cortistatin A, a ‘block-and-lock’strategy for HIV-1 cure CF Kessing, CC Nixon, C Li, PM Tsai, H Takata, G Mousseau, PT Ho, ... Journal of Virus Eradication	181	2017
The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries AM Hill, S Nath, B Simmons Journal of Virus Eradication 3 (3), 117-123	123	2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? A Hill, SL Hughes, D Gotham, AL Pozniak Journal of Virus Eradication 4 (2), 72-79	98	2018
Are new antiretroviral treatments increasing the risks of clinical obesity? A Hill, L Waters, A Pozniak Journal of Virus Eradication 5 (1), 41-43	82	2019
Establishment of latent HIV-1 reservoirs: what do we really know? J Vanhamel, A Bruggemans, Z Debyser Journal of Virus Eradication 5 (1), 3-9	74	2019
Minimum costs to manufacture new treatments for COVID-19 A Hill, J Wang, J Levi, K Heath, J Fortunak Journal of Virus Eradication 6 (2), 61-69	72	2020
How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP V Pilkington, A Hill, S Hughes, N Nwokolo, A Pozniak Journal of Virus Eradication 4 (4), 215-224	68	2018
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines E Wright, A Grulich, K Roy, M Boyd, V Cornelisse, D Russell, D O'Donnell, ... Journal of Virus Eradication 3 (3), 168-184	62	2017
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir C Gaebler Journal of Virus Eradication	59	2019
Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US K Dubé, D Evans, L Sylla, J Taylor, BJ Weiner, A Skinner, H Thirumurthy, ... Journal of Virus Eradication 3 (1), 40-71	56	2017
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals S Popping, D Bade, C Boucher, M van der Valk, M El-Sayed, O Sigurour, ... Journal of Virus Eradication 5 (1), 60-66	51	2019
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018 E Wright, A Grulich, K Roy, M Boyd, V Cornelisse, D Russell, D O'Donnell, ... Journal of Virus Eradication 4 (3), 143-159	49	2018
Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19 T Pepperrell, V Pilkington, A Owen, J Wang, AM Hill Journal of Virus Eradication 6 (2), 52-60	49	2020
Impact of COVID-19 on people living with HIV: A review S Prabhu, S Poongulali, N Kumarasamy Journal of Virus Eradication 6 (4), 100019	46	2020
Achieving UNAIDS 90-90-90 targets for pregnant and postpartum women in sub-Saharan Africa: progress, gaps and research needs LL Abuogi, JM Humphrey, C Mpody, M Yotebieng, PM Murnane, K Clouse, ... Journal of Virus Eradication 4, 33-39	45	2018
Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations SA Garner, S Rennie, J Ananworanich, K Dube, DM Margolis, ... Journal of Virus Eradication 3 (2), 82-84	44	2017
Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review A drew Hill, P Clayden, C Thorne, R Christie, R Zash Journal of Virus Eradication 4 (2), 66-71	43	2018
Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B. 1.1. 7, United Kingdom), Beta (B. 1.351, South Africa), Gamma (P. 1, Brazil) and Delta (B. 1.617. 2, India) PRS Sanches, I Charlie-Silva, HLB Braz, C Bittar, MF Calmon, P Rahal, ... Journal of Virus Eradication 7 (3), 100054	37	2021
Tat inhibition by didehydro-cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat C Li, S Valente, G Mousseau Journal of Virus Eradication	37	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。